SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Trinity Biotech (TRIBY)
TRIB 0.820-6.8%Jan 30 9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: AgAuUSA who wrote (8514)3/12/1998 12:44:00 PM
From: Scott H. Davis  Read Replies (1) of 14328
 
Greg, 4.50 is probably overkill. Projecting current PE of 33 * .09 yields 2.97. Add in an additional pop from and FDA approval or a good SLF announcement and maybe you get $3.50, but that's pushing it.
no major bad news along the way, a lot more shares don't enter the market. Remember those possible pop sources are already build into the price to some extent.

What's the PE of the S&P now, about 25? TRIBY has frustrated a lot of people so there will be sales from frustrated shareholders as they break even, then there's a lot of profit taking to deal with. A lot of shares have been bought around 1.87-2.03, so folks will be taking money off the table along the way.

Remember to base expectations on projected growth FROM CURRENT SHARE PRICE, not our cost basis, or what we think TRIBY should be priced at. I'd be tickled to death to see 4.50 in two years, or 50% annually. Note I'm not predicting that much. IMSCO Scott
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext